• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows

    7/1/24 1:38:37 PM ET
    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADBE alert in real time by email

    June closed on a high note for the stock market, with the S&P 500, tracked by the SPDR S&P 500 ETF Trust (NYSE:SPY), gaining 3.2%, despite significant disparities in sector and industry performances.

    The technology sector, as tracked by the Technology Select Sector SPDR Fund (NYSE:XLK), led the 11 S&P 500 sectors in performance last month, surging 7.7% and achieving its strongest monthly gain this year.

    In stark contrast, utilities lagged, with the Utilities Select Sector SPDR Fund (NYSE:XLU) dropping 6.3%, marking the worst month since September 2023.

    Top Performing Industry ETFs In June

    The iShares Expanded Tech-Software Sector ETF (NYSE:IGV) rallied 11.3% last month, topping the rankings among industry ETFs.

    Hot on its heels was the VanEck Semiconductor ETF (NYSE:SMH), which climbed 8.4%, showcasing strong momentum in the semiconductor sector.

    Since hitting its low in October 2023, the VanEck Semiconductor ETF has rallied by an astounding 87%, and over 200% since October 2022, reflecting the spectacular growth in AI-driven stocks.

    Securing the third spot in terms of monthly performance, the SPDR S&P Biotech ETF (NYSE:XBI) gained 4%.

    Within the software sector, standout performers included Adobe Inc. (NASDAQ:ADBE), which surged by 24.9%, CrowdStrike Holdings, Inc. (NASDAQ:CRWD) with a 22.1% increase, and Oracle Corporation (NYSE:ORCL), up by 20%.

    Broadcom Inc. (NASDAQ:AVGO) led chipmakers with a 21% rise. Universal Display Corporation (NYSE:OLED) followed closely with a 19.7% increase, and Qorvo, Inc. (NASDAQ:QRVO) posted an 18% gain.

    Among chipmakers, Broadcom Inc. (NASDAQ:AVGO), Universal Display Corporation (NYSE:OLED) and Qorvo, Inc. (NASDAQ:QRVO) led gains, with performances of 21%, 19.7% and 18%, respectively.

    In the biotech arena, Scilex Holding Company (NASDAQ:SCLX) experienced a 78.8% spike, making it the top industry gainer. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) surged by 63.7%, while Avidity Biosciences, Inc. (NASDAQ:RNA) saw a robust 52% increase.

    Top Performing Industry ETFs By Inflows In June

    Examining fund flows, the VanEck Semiconductor ETF has emerged as a top choice for investors, attracting over $1 billion according to Tradingview data, and achieving its ninth consecutive month of inflows. Year-to-date the fund has registered $4.60 billion in net inflows.

    The iShares Expanded Tech-Software Sector ETF pulled in approximately $480 million in June, breaking a six-month streak of outflows and registering its highest monthly inflows since September 2022. Yet, its year-to-date net flows are still negative, down by $1.15 billion.

    The iShares Biotechnology ETF (NYSE:IBB) collected $148 million in inflows last month, reflecting strong investor interest. Another industry witnessing robust inflows was represented by the Global X Copper Miners ETF (NYSE:COPX), which attracted about $130 million.

    Read Next:

    • Manufacturing Contracts More Than Expected In June, ‘Putting Pressure On Profitability’: Yields Rise, Stocks Fall

    Photo: Shutterstock

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $ALNY
    $AVGO
    $CRWD

    CompanyDatePrice TargetRatingAnalyst
    Oracle Corporation
    $ORCL
    2/9/2026Buy → Hold
    Melius
    Oracle Corporation
    $ORCL
    2/9/2026$180.00Neutral → Buy
    DA Davidson
    Oracle Corporation
    $ORCL
    2/4/2026$270.00 → $205.00Outperform
    BMO Capital Markets
    Adobe Inc.
    $ADBE
    2/3/2026$330.00Overweight → Neutral
    Piper Sandler
    Broadcom Inc.
    $AVGO
    1/30/2026$400.00Peer Perform → Outperform
    Wolfe Research
    Alnylam Pharmaceuticals Inc.
    $ALNY
    1/28/2026$527.00Overweight
    Barclays
    Qorvo Inc.
    $QRVO
    1/28/2026$110.00 → $95.00Buy
    Craig Hallum
    Qorvo Inc.
    $QRVO
    1/28/2026$95.00 → $80.00Hold
    TD Cowen
    More analyst ratings

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Oracle Health Clinical AI Agent, Clinical Note Helps UK Doctors Spend More Time on Patient Care

    AI-powered agent for clinical notes is now available in the UK after demonstrating significant benefits at NHS Trusts Oracle Health Clinical AI Agent reduces documentation time, freeing time for more meaningful patient interaction LONDON, Feb. 12, 2026 /PRNewswire/ -- Following a successful pilot program at several NHS Trusts, Oracle Health today announced its Clinical AI Agent, Clinical Note is now available in the UK. The new AI solution allows caregivers at the NHS and private practices to use an ambient voice and screen-driven assistant to draft patient notes, so they can reduce administrative tasks and devote more time to patient care. Trusts participating in the pilot program, includin

    2/12/26 4:15:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Hillsboro Health Chooses AI-Powered Oracle Health Solutions to Help Advance Patient Care, Optimize Operations

    Will unify health record systems with Oracle Health Foundation EHR, implement Oracle Health Clinical AI Agent and Oracle Health Seamless Exchange across its network AUSTIN, Texas, Feb. 11, 2026 /PRNewswire/ -- Hillsboro Health, an independent, 25-bed critical access hospital based in Hillsboro, Illinois, has chosen Oracle Health solutions to help accelerate innovation, drive operational efficiencies, and enhance patient care. In addition to transitioning from legacy systems to an integrated Oracle Health Foundation EHR, Hillsboro Health plans to leverage Oracle Health Clinical AI Agent, an AI-powered, voice-driven solution, to automate clinical documentation and enable providers to dedicate

    2/11/26 8:05:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Cloud Infrastructure to Support Centers for Medicare and Medicaid's Modernization Initiative

    OCI to bolster federal health agency's mission critical systems AUSTIN, Texas, Feb. 11, 2026 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) has selected Oracle Cloud Infrastructure (OCI) to consolidate and migrate select on-premises workloads to the cloud. OCI will support CMS' modernization efforts by providing secure, scalable cloud infrastructure for the agency's mission-critical systems. By migrating to OCI, CMS will leverage Oracle's FedRAMP® High-authorized infrastructure to meet the most stringent federal security and compliance requirements, along w

    2/11/26 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    SEC Filings

    View All

    Qorvo Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Qorvo, Inc. (0001604778) (Filer)

    2/11/26 5:16:35 PM ET
    $QRVO
    Semiconductors
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Avidity Biosciences Inc.

    SCHEDULE 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)

    2/10/26 11:23:20 AM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 425 filed by Qorvo Inc.

    425 - Qorvo, Inc. (0001604778) (Subject)

    2/6/26 6:42:32 AM ET
    $QRVO
    Semiconductors
    Technology

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Magouyrk Clayton M. sold $1,552,318 worth of shares (10,000 units at $155.23), decreasing direct ownership by 7% to 134,030 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    2/11/26 4:42:45 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    PRESIDENT AND CEO Kurtz George sold $11,916,487 worth of shares (28,853 units at $413.01), decreasing direct ownership by 1% to 2,054,902 units (SEC Form 4)

    4 - CrowdStrike Holdings, Inc. (0001535527) (Issuer)

    2/5/26 8:00:05 PM ET
    $CRWD
    Computer Software: Prepackaged Software
    Technology

    CHIEF FINANCIAL OFFICER Podbere Burt W. sold $3,272,586 worth of shares (7,871 units at $415.78), decreasing direct ownership by 4% to 169,613 units (SEC Form 4)

    4 - CrowdStrike Holdings, Inc. (0001535527) (Issuer)

    2/5/26 8:00:07 PM ET
    $CRWD
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director You Harry L. bought $325,129 worth of shares (1,000 units at $325.13), increasing direct ownership by 3% to 36,602 units (SEC Form 4)

    4 - Broadcom Inc. (0001730168) (Issuer)

    12/22/25 5:34:40 PM ET
    $AVGO
    Semiconductors
    Technology

    Director You Harry L. bought $1,227,870 worth of shares (3,550 units at $345.88), increasing direct ownership by 11% to 35,602 units (SEC Form 4)

    4 - Broadcom Inc. (0001730168) (Issuer)

    9/10/25 9:07:35 PM ET
    $AVGO
    Semiconductors
    Technology

    Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    7/9/25 4:39:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oracle downgraded by Melius

    Melius downgraded Oracle from Buy to Hold

    2/9/26 9:24:14 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle upgraded by DA Davidson with a new price target

    DA Davidson upgraded Oracle from Neutral to Buy and set a new price target of $180.00

    2/9/26 6:56:02 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    BMO Capital Markets reiterated coverage on Oracle with a new price target

    BMO Capital Markets reiterated coverage of Oracle with a rating of Outperform and set a new price target of $205.00 from $270.00 previously

    2/4/26 7:57:19 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for GIVLAARI issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug GIVLAARI (SUPPL-7) with active ingredient GIVOSIRAN SODIUM has changed to 'Approval' on 04/29/2024. Application Category: NDA, Application Number: 212194, Application Classification: Labeling

    4/30/24 1:44:03 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OXLUMO issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug OXLUMO (SUPPL-4) with active ingredient LUMASIRAN SODIUM has changed to 'Approval' on 09/19/2023. Application Category: NDA, Application Number: 214103, Application Classification: Labeling

    9/20/23 2:36:38 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for AMVUTTRA issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug AMVUTTRA (SUPPL-2) with active ingredient VUTRISIRAN has changed to 'Approval' on 02/16/2023. Application Category: NDA, Application Number: 215515, Application Classification: Labeling

    2/17/23 12:30:09 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Avidity Biosciences Inc.

    SC 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)

    11/14/24 5:46:11 PM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Avidity Biosciences Inc.

    SC 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)

    11/14/24 1:22:38 PM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by CrowdStrike Holdings Inc.

    SC 13G/A - CrowdStrike Holdings, Inc. (0001535527) (Subject)

    11/14/24 1:22:38 PM ET
    $CRWD
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Leadership Updates

    Live Leadership Updates

    View All

    Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel

    PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, announced that it has appointed Kasowitz LLP and its founding partner Marc Kasowitz as the Company's litigation and intellectual property counsel. Kasowitz LLP will advise Scilex on complex commercial litigation, patent litigation, intellectual property enforcement and defense, licensing matters, and strategic intellectual property governance as the C

    1/2/26 9:00:00 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Scientists Pointing to Hidden Power Source That Could Reshape Future of AI

    This article has been disseminated on behalf of MAX Power Mining Corp. and may include a paid advertisement. AUSTIN, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) -- MiningNewsWire: Global electricity demand is reaching a pivotal turning point. The International Energy Agency (IEA) now projects that global data-center electricity use will almost double by 2030, with AI-focused facilities increasing their consumption more than four times over the same span — a trajectory pushing power grids in the United States, China, Europe, Southeast Asia and other regions to their limits. The bottleneck is no longer data throughput or semiconductor performance; the critical constraint has become electricity it

    12/3/25 8:30:00 AM ET
    $AMZN
    $AVGO
    $META
    Catalog/Specialty Distribution
    Consumer Discretionary
    Semiconductors
    Technology

    Alnylam Pharmaceuticals Announces Changes to Board of Directors

    – Mike Bonney and Carolyn Bertozzi to Depart; Company Appoints Stuart Arbuckle as New Independent Director – Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, today announced changes to its Board of Directors, including the departure of two directors and the appointment of a new independent director. Mike Bonney and Carolyn Bertozzi, Ph.D., who have served in key roles on Alnylam's Board, stepped down effective December 2, 2025. Mr. Bonney joined our Board in 2014 and served as Board Chair from December 2015 to August 2021 and as Executive Chair from August 2021 to January 2023. He helped to guide the company through major milestones and significant growt

    12/3/25 8:00:00 AM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Financials

    Live finance-specific insights

    View All

    CrowdStrike Announces Date of Fourth Quarter and Fiscal Year 2026 Financial Results Conference Call

    CrowdStrike Holdings, Inc. (NASDAQ:CRWD), today announced that it will release financial results for its fourth quarter and fiscal year 2026 ended January 31, 2026 after the U.S. market close on Tuesday, March 3, 2026. CrowdStrike will host a conference call that day at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) to discuss the results. To register for the live event please visit https://crowdstrike-fiscal-fourth-quarter-2026-results-conference-call.open-exchange.net/ A live webcast of the conference call and the financial results press release will be accessible from the CrowdStrike investor relations website at ir.crowdstrike.com. An audio webcast replay of the conference call wil

    2/3/26 8:30:00 AM ET
    $CRWD
    Computer Software: Prepackaged Software
    Technology

    Broadcom Inc. to Announce First Quarter Fiscal Year 2026 Financial Results on Wednesday, March 4, 2026

    PALO ALTO, Calif., Feb. 2, 2026 /PRNewswire/ -- Broadcom Inc. (NASDAQ:AVGO), a technology leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced it will report its first quarter fiscal year 2026 financial results and business outlook on Wednesday, March 4, 2026 after the close of the market. Broadcom's management will host a conference call at 2:00 p.m. Pacific Time on the same day to discuss these results and business outlook. Date: Wednesday, March 4, 2026 Time: 2:00 PM (PT); 5:00 PM (ET) Listen via Internet: The conference call can be accessed live online in the Investors section of the Broadcom website at https://investors.broadco

    2/2/26 8:00:00 AM ET
    $AVGO
    Semiconductors
    Technology

    Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results

    Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the fourth quarter and year ending December 31, 2025 on Thursday, February 12, 2026, before the U.S. financial markets open. Management will provide an update on the Company and discuss fourth quarter and year-end 2025 results as well as expectations for the future via conference call on Thursday, February 12, 2026 at 8:30 am ET. A live audio webcast of the call will be available on the Investors section of the Company's website at www.alnylam.com/events. An archived webcast will be available on the Alnylam website approximately two hours after the

    1/29/26 8:00:00 AM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care